Herceptin Sales Data

Rank 25 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Herceptin U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 25 (1) 1.53% 3.09%
Q3 2013 24 (2) -0.30% -2.41%
Q2 2013 26 (2) -0.74% -0.60%
Q1 2013 24 1.43% 1.83%
Q4 2012 24 (2) 3.22% 1.23%
Q3 2012 26 (4) -0.84% -0.61%
Q2 2012 30 (3) 6.67% 5.16%
Q1 2012 33 -0.06%
Q4 2011 33 (2) 7.61% 4.73%
Q3 2011 31 (1) -0.64% -0.67%
Q2 2011 32 (4) 3.62% 1.36%
Q1 2011 36

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
September 29, 2014Drug Gives Big Survival Boost Against Type of Advanced Breast Cancer
November 26, 2013Mylan-Biocon Receive First Indian Biosimilar Regulatory Approval for Herceptin
October 5, 2011Drug Combo Might Fight Aggressive Breast Cancer More Safely
August 10, 2011Breast Cancer Drug Raises Risk of Heart Problems in Older Women: Study
June 14, 2011FDA Approves Test That Spots HER2-Positive Breast Cancers
June 14, 2011New Test Helps Evaluate Breast Cancer Patients for Herceptin Use
February 24, 2011Herceptin May Boost Long-Term Survival After Aggressive Breast Cancer
October 21, 2010Roche: FDA Approves Herceptin for Stomach Cancer
January 28, 2010Herceptin Again Proves Mettle Against Breast Cancer
December 14, 2009Novel Drug Combo Improves Breast Cancer Survival
December 12, 2009Chemo With Herceptin May Be Best for Some Breast Cancers
November 3, 2009Drug Could Help Treat Small HER2-Positive Breast Tumors
September 14, 2009Routine Testing Would Improve Herceptin Use in Breast Cancer
Hide
(web4)